<code id='088BB20871'></code><style id='088BB20871'></style>
    • <acronym id='088BB20871'></acronym>
      <center id='088BB20871'><center id='088BB20871'><tfoot id='088BB20871'></tfoot></center><abbr id='088BB20871'><dir id='088BB20871'><tfoot id='088BB20871'></tfoot><noframes id='088BB20871'>

    • <optgroup id='088BB20871'><strike id='088BB20871'><sup id='088BB20871'></sup></strike><code id='088BB20871'></code></optgroup>
        1. <b id='088BB20871'><label id='088BB20871'><select id='088BB20871'><dt id='088BB20871'><span id='088BB20871'></span></dt></select></label></b><u id='088BB20871'></u>
          <i id='088BB20871'><strike id='088BB20871'><tt id='088BB20871'><pre id='088BB20871'></pre></tt></strike></i>

          leisure time

          leisure time

          author:knowledge    Page View:66131
          Photo illustration based on photograph of The University of Texas MD Anderson Cancer Center in Houston, Texas in 2022
          Photo illustration: STAT; Photo: Adobe

          Three years ago, Jamie Lin, an early-career nephrologist at MD Anderson Cancer Center, made findings that could potentially help both save the kidneys of cancer patients and propel her career as a physician-scientist hoping to one day run her own lab. It was a promising start, but that’s when Lin says one of the Texas institute’s most powerful researchers interfered.

          Lin alleges in a lawsuit that prominent oncologist Padmanee Sharma derailed the publication of papers based on Lin’s work, threatened to undermine her fledgling career, and made defamatory comments about her in retaliation for resisting making Sharma an author on a paper and saying the senior researcher had made no substantial contribution to it.

          advertisement

          “Having this and another paper taken — what would’ve been important papers for my career,” Lin told STAT in an interview. “I’m sure that my career in research has just fallen off a cliff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Juul spent big to court Black leaders to promote its e
          Juul spent big to court Black leaders to promote its e

          StephanieKeith/GettyImagesDocumentsreleasedthisweekshednewlightonanaggressivestrategyfromvapemakerJu

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

          5:16FormerPresidentandRepublicanpresidentialcandidateDonaldTrumptakesthestageduringtheTurningPointAc